These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 35513835)
1. EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression. Yang M; Hu H; Wu S; Ding J; Yin B; Huang B; Li F; Guo X; Han L J Exp Clin Cancer Res; 2022 May; 41(1):165. PubMed ID: 35513835 [TBL] [Abstract][Full Text] [Related]
2. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression. Sui X; Wang Y; Liu H Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278492 [TBL] [Abstract][Full Text] [Related]
3. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway. Jiang Z; Tai Q; Xie X; Hou Z; Liu W; Yu Z; Liang Z; Chen S J Exp Clin Cancer Res; 2021 Jul; 40(1):227. PubMed ID: 34253241 [TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA. Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782 [TBL] [Abstract][Full Text] [Related]
5. EIF4A3-mediated oncogenic circRNA hsa_circ_0001165 advances esophageal squamous cell carcinoma progression through the miR-381-3p/TNS3 pathway. Zhang X; Bian Y; Li Q; Yu C; Gao Y; Tian B; Xia W; Wang W; Xin L; Lin H; Wang L Cell Biol Toxicol; 2024 Oct; 40(1):84. PubMed ID: 39382613 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression. Li L; Liu D; Chen T; Wei C; Qiao Y; Liu W; Liang Y; Liang Z; Chen C; Li D; Wu B; Zhao X; Huang D; Wu D J Exp Clin Cancer Res; 2024 Jul; 43(1):200. PubMed ID: 39030638 [TBL] [Abstract][Full Text] [Related]
7. Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation. Jiang X; Peng M; Liu Q; Peng Q; Oyang L; Li S; Xu X; Shen M; Wang J; Li H; Wu N; Tan S; Lin J; Xia L; Tang Y; Luo X; Liao Q; Zhou Y Mol Cancer; 2024 Jul; 23(1):151. PubMed ID: 39085875 [TBL] [Abstract][Full Text] [Related]
8. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway. Liu Y; Song J; Zhang H; Liao Z; Liu F; Su C; Wang W; Han M; Zhang L; Zhu H; Zhang Z; Liang H; Zhang L; Zhang B; Chen X J Exp Clin Cancer Res; 2022 May; 41(1):164. PubMed ID: 35509064 [TBL] [Abstract][Full Text] [Related]
9. EIF4A3-regulated hsa_circ_0001445 can inhibit the progression of laryngeal squamous cell carcinoma via hsa-miR-432-5p-dependent up-regulation of RGMA expression. Yu M; Cao H; Yang J; Liu T; Gao J; Wang B Cell Cycle; 2023 Sep; 22(18):2038-2056. PubMed ID: 37902305 [TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3. Yuan LX; Luo M; Liu RY; Wang HX; Ju LL; Wang F; Cao YL; Wang ZC; Chen L BMC Cancer; 2024 Feb; 24(1):239. PubMed ID: 38383334 [TBL] [Abstract][Full Text] [Related]
11. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7. Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039 [TBL] [Abstract][Full Text] [Related]
12. EIF4A3-Induced Upregulation of hsa_circ_0049396 Attenuates the Tumorigenesis of Nasopharyngeal Carcinoma by Regulating the Hippo-YAP Pathway. Zhou Q; Cai B; Liu K; Chen H DNA Cell Biol; 2024 Oct; 43(10):510-519. PubMed ID: 39133108 [TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis. Zhang M; Sun Y; Xu H; Shi Y; Shen R; Teng F; Xu J; Jia X Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):574-586. PubMed ID: 37057923 [TBL] [Abstract][Full Text] [Related]
14. circ-SIRT1 Promotes Colorectal Cancer Proliferation and EMT by Recruiting and Binding to eIF4A3. Wang X; Liu S; Xu B; Liu Y; Kong P; Li C; Li B Anal Cell Pathol (Amst); 2021; 2021():5739769. PubMed ID: 34660182 [TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma. Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015 [TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling. Ge P; Chen X; Liu J; Jing R; Zhang X; Li H Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942 [TBL] [Abstract][Full Text] [Related]
17. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877 [TBL] [Abstract][Full Text] [Related]
18. EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis. Huang X; Tan W; Liu Z; Fu X; Li Z; Lai S; Li Q; Zhong X; Qu F; Zhang H; Li H Life Sci; 2023 Jul; 324():121745. PubMed ID: 37127184 [TBL] [Abstract][Full Text] [Related]
19. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis. Jin J; Liu H; Jin M; Li W; Xu H; Wei F Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866 [TBL] [Abstract][Full Text] [Related]
20. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance. Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]